SOPHARMA AD (71/2023) Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 21 June 2023.
Report no 71/2023
- 22.06.2023, 11:21
- Kategoria: Biznes i finanse
- Źródło: ESPI
Sopharma AD-BG11SOSOBT18-SOPHARMA
-
SOPHARMA AD (70/2023) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 21 June 2023.
Report no 70/2023- 22.06.2023, 11:15
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (68/2023) Notification from Rositsa Doneva under Art. 19 of Regulation (EU) No 596/2014 of 20 June 2023.
Report no 68/2023- 21.06.2023, 12:51
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (67/2023) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 20 June 2023.
Report no 67/2023- 21.06.2023, 12:49
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (65/2023) Notification from Rositsa Doneva under Art. 19 of Regulation (EU) No 596/2014 of 19 June 2023.
Report no 65/2023- 20.06.2023, 13:51
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (64/2023) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 19 June 2023.
Report no 64/2023- 20.06.2023, 13:46
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (63/2023) Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 19 June 2023.
Report no 63/2023- 20.06.2023, 13:41
- Kategoria: Biznes i finanse
- Źródło: ESPI
-
SOPHARMA AD (62/2023) Sales revenues for May 2023
Report no 62/2023- 20.06.2023, 13:03
- Kategoria: Biznes i finanse
- Źródło: ESPI
